Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by brad129on Dec 06, 2020 3:25pm
137 Views
Post# 32046485

RE:RE:RE:RE:Anyone think

RE:RE:RE:RE:Anyone think

Just caught up on weekend posts, some great ones. We shouldn't have to fear of being poached since we are to be first to market, can't poach if you don't have a product to undercut us with. Aristotle news needs to come out, Clarus was calling for an update on partnerships imminent months ago. For me imminent means like very soon, as in a week to a month. Hopefully this week the wind starts blowing in the right direction not against our sails.



Jonnyboy85 wrote: Definitely, I think it's been hard on all of us waiting to hear about the partnerships we have lined up for Aristotle. Being kept in the dark isn't fun, especially when money is concerned, and going on faith alone has been trying as is. But I definitely get why they have to keep the partnerships quiet until the full launch, the big players in the market would be watching so they can poach or retain/renegotiate current contracts before we can move them over to szls, and we definitely don't want to be undercut before our product even hits the market.
 

Mykndrsn wrote: Any word on Aristotle partnerships will be huge. If not now certainly very soon. This has been coming for years,  patient invvesors will be rewarded.




<< Previous
Bullboard Posts
Next >>